Bioatla Inc (BCAB)

Jun 14, 2025

BioAtla, Inc. (NASDAQ:BCAB) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 14, 2025

Jun 09, 2025

Jane Street Group LLC Purchases 100,204 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 09, 2025

Jun 09, 2025

BioAtla, Inc. (NASDAQ:BCAB) Stock Position Lowered by Two Sigma Advisers LP - Defense World

Jun 09, 2025

Jun 08, 2025

Millennium Management LLC Cuts Stock Position in BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Jun 08, 2025

Jun 07, 2025

BioAtla (NASDAQ:BCAB) Upgraded by Wall Street Zen to Hold Rating - Defense World

Jun 07, 2025

Jun 06, 2025

BioAtla presents Phase 2 Oz-V clinical trial data at ASCO 2025 - MSN

Jun 06, 2025

Jun 03, 2025

Why Did BioAtla Inc (NASDAQ: BCAB) Drop So Much? - Stocksregister

Jun 03, 2025

Jun 03, 2025

BioAtla reports promising trial results for cancer drug By Investing.com - Investing.com South Africa

Jun 03, 2025

Jun 02, 2025

BioAtla reports promising trial results for cancer drug - Investing.com

Jun 02, 2025

Jun 02, 2025

BioAtla (BCAB) Showcases Promising Data for Ozuriftamab Vedotin in Key Cancer Trial | BCAB Stock News - GuruFocus

Jun 02, 2025

Jun 02, 2025

BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen - The Manila Times

Jun 02, 2025

Jun 02, 2025

BioAtla's New Cancer Drug Achieves 13x Better Response Rate Than Standard Treatment in Phase 2 Trial - Stock Titan

Jun 02, 2025

May 28, 2025

BioAtla’s SWOT analysis: CAB platform stock faces pivotal year amid clinical trials - Investing.com Nigeria

May 28, 2025

May 19, 2025

Dimensional Fund Advisors LP Sells 86,264 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

May 19, 2025

May 17, 2025

BioAtla receives Nasdaq delisting warning By Investing.com - Investing.com India

May 17, 2025

May 16, 2025

BioAtla receives Nasdaq delisting warning - Investing.com Australia

May 16, 2025

May 16, 2025

BioAtla Receives Nasdaq Non-Compliance Notice - TipRanks

May 16, 2025

May 12, 2025

HC Wainwright Issues Negative Estimate for BioAtla Earnings - Defense World

May 12, 2025

May 11, 2025

HC Wainwright Predicts BioAtla’s Q1 Earnings (NASDAQ:BCAB) - Defense World

May 11, 2025

May 10, 2025

BioAtla Inc (NASDAQ: BCAB): Is Its Value Too High Compared To Others? - Stocksregister

May 10, 2025

May 08, 2025

Analysts Offer Insights on Healthcare Companies: BioAtla (BCAB), Relay Therapeutics (RLAY) and Crispr Therapeutics AG (CRSP) - The Globe and Mail

May 08, 2025

May 07, 2025

BioAtla stock holds $1 target, JMP affirms Market Outperform By Investing.com - Investing.com Nigeria

May 07, 2025

May 07, 2025

BioAtla at Citizens JMP Life Sciences: Strategic Partnerships in Focus By Investing.com - Investing.com India

May 07, 2025

May 07, 2025

BioAtla at Citizens JMP Life Sciences: Strategic Partnerships in Focus - Investing.com Australia

May 07, 2025

May 07, 2025

Bioatla Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025

May 07, 2025

Gaining Ground: BioAtla Inc (BCAB) Closes Lower at 0.48, Down -8.19 - DWinneX

May 07, 2025

May 07, 2025

BioAtla, Inc. (NASDAQ:BCAB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

May 07, 2025

BioAtla Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025

May 07, 2025

BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress - The Manila Times

May 07, 2025

May 07, 2025

BioAtla Inc (BCAB) Q1 2025 Earnings Call Highlights: Promising Clinical Progress Amid Financial ... By GuruFocus - Investing.com Canada

May 07, 2025

May 07, 2025

BioAtla (NASDAQ:BCAB) vs. Novavax (NASDAQ:NVAX) Head-To-Head Comparison - Defense World

May 07, 2025

May 07, 2025

Bioatla, Inc. Earnings Call Highlights Clinical Success - TipRanks

May 07, 2025

May 07, 2025

BioAtla, Inc. Reports Q1 2025 Financial Results - TipRanks

May 07, 2025

May 06, 2025

Earnings call transcript: Bioatla beats Q1 2025 earnings expectations - Investing.com

May 06, 2025

May 06, 2025

BioAtla, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:BCAB) - Seeking Alpha

May 06, 2025

May 06, 2025

BioAtla (BCAB) Advances Cancer Treatment with Promising Study Re - GuruFocus

May 06, 2025

May 06, 2025

Earnings call transcript: Bioatla beats Q1 2025 earnings expectations By Investing.com - Investing.com UK

May 06, 2025

May 06, 2025

BioAtla (BCAB) Advances Cancer Treatment with Promising Study Results | BCAB Stock News - GuruFocus

May 06, 2025

May 06, 2025

BioAtla reports Q1 EPS (26c), consensus (29c) - TipRanks

May 06, 2025

May 06, 2025

BioAtla Reports Breakthrough: Cancer Drug Triples Survival Rate vs Standard Treatment in Lung Cancer Study - Stock Titan

May 06, 2025

May 04, 2025

BioAtla, Inc. (NASDAQ:BCAB) Shares Acquired by Renaissance Technologies LLC - Defense World

May 04, 2025

May 02, 2025

There is no doubt that BioAtla Inc (BCAB) ticks all the boxes. - Sete News

May 02, 2025

May 01, 2025

BioAtla Inc (BCAB) shows promising results - uspostnews.com

May 01, 2025

Apr 30, 2025

BioAtla Reveals Next-Gen Cancer Treatment Progress: Key Updates Coming at Citizens Conference - Stock Titan

Apr 30, 2025

Apr 30, 2025

BCAB: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

Apr 30, 2025

Apr 30, 2025

An Analysis of BioAtla Inc (BCAB)’s Potential Price Growth - knoxdaily.com

Apr 30, 2025

Apr 29, 2025

BioAtla Q1 2025 Earnings: Biotech Leader to Share Latest Cancer Treatment Progress on May 6 - Stock Titan

Apr 29, 2025

Apr 29, 2025

BioAtla to Announce First Quarter 2025 Financial Results and Provide Business Highlights on May 6, 2025 - Yahoo Finance

Apr 29, 2025

Apr 27, 2025

Bank of Montreal Can Sells 522,252 Shares of BioAtla, Inc. (NASDAQ:BCAB) - Defense World

Apr 27, 2025